MINI FUTURE LONG - BB BIOTECH N Share Price

Certificat

DE000PB3VSM6

Market Closed - Börse Stuttgart 01:50:25 07/05/2024 pm IST
10.41 EUR +1.86% Intraday chart for MINI FUTURE LONG - BB BIOTECH N
Current month+7.54%
1 month-1.14%
Date Price Change Volume
07/24/07 10.41 +1.86% 0
06/24/06 10.22 -1.64% 0
03/24/03 10.39 +4.11% 0
02/24/02 9.98 +3.10% 0
30/24/30 9.68 +4.20% 0

Delayed Quote Börse Stuttgart

Last update May 07, 2024 at 01:50 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying BB BIOTECH AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PB3VSM
ISINDE000PB3VSM6
Date issued 03/03/2016
Strike 22.34 CHF
Maturity Unlimited
Parity 2 : 1
Emission price 3.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 29.5
Lowest since issue 1.89

Company Profile

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.
Sector
-
More about the company

Ratings for BB Biotech AG

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: BB Biotech AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
42.45 CHF
Average target price
47.7 CHF
Spread / Average Target
+12.37%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW